4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Uni-Bio Science Group Limited (0690) operates in the Biotechnology industry and is headquartered in Sha Tin, Hong Kong with about 543 employees. Its market capitalization is roughly HKD 418 million. In the fiscal year ended 2025-12-31, 0690 reported HKD 586M in revenue and HKD 93M in net income.
Uni-Bio Science Group Limited, an investment holding company, researches and develops, manufactures, and sells biological and chemical pharmaceutical products to treat human diseases in Hong Kong, and People's Republic of China.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | HKD 586M | HKD 553M | HKD 485M | HKD 440M | — |
| Gross Profit | HKD 488M | HKD 461M | HKD 393M | HKD 335M | — |
| Operating Income (EBIT) | HKD 100M | HKD 90M | HKD 68M | HKD 42M | — |
| Net Income | HKD 93M | HKD 83M | HKD 71M | HKD 38M | — |
HKD; HKDM / HKDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | (HKD 16M) | — | — | — | — |
HKD; HKDM / HKDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | HKD 580M | HKD 518M | HKD 410M | HKD 292M | — |
| Total Liabilities | HKD 167M | HKD 192M | HKD 153M | HKD 98M | — |
HKD; HKDM / HKDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 0690 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms